Product Information

OXAZEPAM 30 MG CAPSULE is a generic product labeled by TruPharma LLC, priced at $1.3802 per EA under NDC 52817029210. Its NADAC has been published 153 times since Dec 2, 2020.

The High Outlier badge above means this manufacturer's average price in the Oxazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OXAZEPAM 30 MG CAPSULE

Oxazepam
$1.3802per EA
High Outlier
DEA Schedule CIV

Strength

30 mg/1

Manufacturer

TruPharma LLC

NDC

52817029210

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

2/19/2025

Active Ingredients

OXAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA071026

On Market Since

6/1/2021

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for OXAZEPAM 30 MG CAPSULE has been published 153 times since Dec 2, 2020, and over the history we have for it it has declined 3.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3802 per EA
All-time high$1.4232 (Aug 11, 2021)
All-time low$1.2356 (Apr 20, 2022)
Median price$1.3410
Average price$1.3303
Largest weekly change-13.2% (Apr 20, 2022)
Weeks tracked153
Tracking sinceDec 2, 2020

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+11.7%

5Y

-3.0%

All

-3.0%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OXAZEPAM 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 30 MG CAPSULE, manufactured by TruPharma LLC, is $1.3802 per EA (NDC 52817029210), effective Mar 5, 2025.

How has the price of OXAZEPAM 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for OXAZEPAM 30 MG CAPSULE has declined 3.0%. It has been tracked across 153 weekly CMS publications since Dec 2, 2020.

What are the highest and lowest recorded NADAC prices for OXAZEPAM 30 MG CAPSULE?

Since Dec 2, 2020, the NADAC for OXAZEPAM 30 MG CAPSULE has ranged from a low of $1.2356 (Apr 20, 2022) to a high of $1.4232 (Aug 11, 2021), with a median of $1.3410 per EA.

Are there cheaper alternatives to OXAZEPAM 30 MG CAPSULE?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OXAZEPAM 30 MG CAPSULE, is $1.1370 per EA — about 18% below OXAZEPAM 30 MG CAPSULE.

Who manufactures OXAZEPAM 30 MG CAPSULE?

OXAZEPAM 30 MG CAPSULE (NDC 52817029210) is labeled by TruPharma LLC, and CMS classifies it as a generic product.